World Equity Group’s VanEck Biotech ETF BBH Stock Holding History

World Equity Group’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,000	Closed	-$282K	–	330
2022 Q3	$282K	Hold	2,000	–	–	0.07%	253
2022 Q2	$292K	Hold	2,000	–	–	0.07%	256
2022 Q1	$324K	Buy	+2,000	New	+$324K	0.07%	263

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PGFC

Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return

CIG

Consolidated Investment Group Englewood, Colorado $922M AUM 28.87% 1-Year Est. Return

World Equity Group's BBH Position: Q4 2022 in Review

World Equity Group sold out of VanEck Biotech ETF (BBH) in Q4 2022, closing a stake of 2,000 shares — an estimated $282K sold.

World Equity Group first reported a position in BBH in Q1 2022 and held it in 3 quarters. The position peaked at $324K in Q1 2022. 120 funds tracked by Wall St. Rank hold BBH as of Q4 2022.

World Equity Group reported no remaining VanEck Biotech ETF position as of Q4 2022 after selling out during the quarter.
World Equity Group sold 2,000 VanEck Biotech ETF shares in Q4 2022, an estimated $282K.
World Equity Group first reported a position in VanEck Biotech ETF in Q1 2022 and held it in 3 quarters.
World Equity Group's VanEck Biotech ETF position peaked at $324K in Q1 2022.
120 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2022.

Based on World Equity Group's 13F filing for Q4 2022, filed 6 Sep 2024.